CVE-2026-83193

Received Received - Intake

Siebel Apps - Life Sciences Privilege Escalation

Publication date: 2026-09-15

Last updated on: 2026-09-15

Assigner: Oracle

Description

Vulnerability in the Siebel Apps - Life Sciences product of Oracle Siebel CRM (component: Life Sciences). Supported versions that are affected are 17.0-26.7. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Siebel Apps - Life Sciences executes to compromise Siebel Apps - Life Sciences. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in takeover of Siebel Apps - Life Sciences. CVSS 3.1 Base Score 7.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H).

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published

2026-09-15

Last Modified

2026-09-15

Generated

2026-10-06

AI Q&A

2026-09-16

EPSS Evaluated

2026-10-04

NVD

CVE-2026-83193

EUVD

EUVD-2026-79545

Affected Vendors & Products

Vendor	Product	Version / Range
oracle	siebel_crm	From 17.0 (inc) to 26.7 (inc)

Helpful Resources

Exploitability

CWE

KEV

CWE ID	Description
CWE-UNKNOWN

Attack-Flow Graph

Executive Summary

This is a vulnerability in Oracle Siebel CRM's Life Sciences product affecting versions 17.0 to 26.7. It allows a low-privileged attacker with system access to potentially take over the application. Exploitation requires human interaction from another user and can impact confidentiality, integrity, and availability of the system.

Detection Guidance

Detection requires checking for vulnerable versions of Oracle Siebel Apps - Life Sciences (17.0-26.7). Review installed software versions and compare against the affected range. No specific commands are provided in the context.

Impact Analysis

If exploited, an attacker could gain full control over the Siebel Apps - Life Sciences system. This could lead to unauthorized access to sensitive data, modification or deletion of critical information, and disruption of services. The impact depends on the system's role in your infrastructure.

Compliance Impact

This vulnerability could lead to unauthorized access or modification of sensitive data, which may violate compliance requirements under GDPR, HIPAA, or other regulations. Organizations using affected versions should assess potential compliance risks and apply patches promptly.

Mitigation Strategies

Apply the latest Oracle Critical Patch Update for Siebel Apps - Life Sciences. Ensure only trusted users have logon access to the infrastructure. Monitor for unusual activity in the application.

Hi! I’m here to help you understand CVE-2026-83193. Ask me anything about the vulnerability, its impact, or mitigation strategies.

0/70